Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Management Statement January-March 2020

“The world is experiencing exceptional challenges. From history and experience we know that eventually crises pass and things gradually normalize. In such an environment, it is crucial that our companies balance the need to manage the challenging day-to-day business with continued focus on the critical investments which will strengthen them long-term. Such investments are just as important today as they were a few months ago.”Johan Forssell, President & CEO of InvestorHighlights during the first quarter ·Adjusted net asset value (NAV) amounted to SEK 437,919m (SEK 572 per share)

Flexion Mobile signs Tales of Wind from Neocraft

The top-tier game from China is the 16th title to be added to the Flexion portfolioLONDON, 22nd of April, 2020 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it has signed an agreement with the Chinese game publisher Neocraft for the game Tales of Wind. According to Sensor Tower the game generated USD 2 million in Google Play in March and will be distributed through Flexion's partner channels Amazon, Samsung and Xiaomi. "We are very excited to work with Neocraft who is part of a new breed of Chinese publishers that focus on overseas

Premix Introduces New Active Antimicrobial Technology to Decrease Food Spoilage and Increase Food Safety

Rajamäki, Finland – April 22, 2020 – Premix, an innovative manufacturer of functional plastic materials, today unveiled Prexelent, a new kind of active antimicrobial technology that prevents problems to health and wellbeing caused by harmful microbes. Premix will now initiate several industrial scale application development projects and invites cooperation enquiries from organizations interested in leveraging the patented technology to tap into new business opportunities.The antimicrobial Prexelent technology aims to constrain the global problem of food spoilage. The technology compounds

Invitation to presentation of ICA Gruppen’s interim report for the first quarter

ICA Gruppen will publish its interim report for the first quarter on Wednesday April 29. In conjunction to this, we are pleased to issue this invitation to a telephone conference for the press and the financial market.Time:  Wednesday April 29 at 10.00 CET ICA Gruppen’s CEO Per Strömberg and CFO Sven Lindskog will present the interim report and answer any subsequent questions. The presentation can be viewed at http://www.icagruppen.se/en/investors To attend the telephone conference: SE: +46 8 566 427 03 UK: +44 333 300 9273 A recorded version of the audio cast will be

AQ Group AB (publ), interim report January - March, 2020

First quarter, January-March 2020in brief · Stable earnings and lower net debt than at the end of last year · Net sales increased by 7.1 % to SEK 1 342 million (1 253) · Operating profit (EBIT) increased by 2.3 % to SEK 98 million (96) · Profit after financial items (EBT) decreased by 6.5 % to SEK 87 million (93) · Profit margin before tax (EBT %) was 6.5 % (7.4) · Cash flow from operating activities decreased to SEK 141 million (165) · Earnings per share after tax SEK 4.11 SEK (4.14) · Equity ratio 54 % (54) · Covid-19 affected the quarter with SEK 25 million

Nel ASA: Annual Report 2019

(Oslo, 22 April 2020) Nel ASA (Nel, OSE: NEL) has published its annual report for 2019. The annual report is attached to this stock exchange notice and published on www.nelhydrogen.com. ENDS For further information, please contact: Kjell Christian Bjørnsen, CFO, +47 917 02 097 About Nel ASA | www.nelhydrogen.com Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store, and distribute hydrogen from renewable energy. We serve industries, energy, and gas companies with leading hydrogen technology. Our roots date back to 1927, and since then, we

Nel ASA: Notice of Annual General Meeting 2020

(Oslo, 22 April 2020) Nel ASA (Nel, OSE: NEL) calls for its annual general meeting to be held at Karenslyst allé 20, 0278 Oslo, Norway on 13 May 2020 at 10:00 (CET).  Please find here attached the convening notice, the proposal from the nomination committee in Nel ASA for the annual general meeting, and statement of the board regarding compensation to leading employees. Relevant documents referred to in the notice and link for registration are made available on www.nelhydrogen.com.   Due to the extraordinary situation with Covid-19, and in light of prevailing meeting

Interim Report for the period January – March 2020

Operations performing according to plan Key events during the first quarter 2020 · As of today, BioArctic has not experienced any noteworthy disruptions to its operations owing to the COVID-19 pandemic. Financial summary January – March 2020 · Net revenues for the period amounted to MSEK 36.4 (63.4), a decrease of 27 MSEK · Operating profit amounted to 3.8 MSEK (17.3) and the operating margin was 10.4 percent (27.3) · Profit for the period amounted to MSEK 3.6 (13.6) and earnings per share were SEK 0.04 (0.15) · Cash flow from operating activities amounted to MSEK -

Fiskars to publish its Interim Report for January-March 2020 on May 6, 2020

Fiskars CorporationPress releaseApril 22, 2020 at 09:00 EEST Fiskars to publish its Interim Report for January-March 2020 on May 6, 2020 Fiskars Corporation will publish its Interim Report for January-March 2020 on May 6, 2020 at approximately 8:30 a.m. (EEST). The Interim Report will be available on the company's website www.fiskarsgroup.com after publication. WebcastA webcast on the first quarter results will be held on May 6, 2020 at 11:00 a.m. It will be held in English and can be followed at: https://fiskars.videosync.fi/2020-q1-results 

Result of placing and issue price

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Faron Pharmaceuticals Oy   Result of Placing and Issue Price and Broker Option Capitalised terms used in this announcement have the meanings given to them in the announcement made at 4.45 p.m. BST/ 6.45

Volume of freight transport has remained high on Viking Line ships despite exceptional circumstances

During the current exceptional circumstances, the transport capacity of Viking Line is being utilised for freight traffic. The traffic has been heavy and the demand for sea transports has grown even further since Easter.During the prevailing exceptional circumstances, Viking Line has been maintaining both goods transports and the related logistic services in order to safeguard the security of supply in Finland. The volume of freight traffic has been heavy. ‘The utilisation rate of the ships' cargo capacity has been 100% on several occasions. Our staff has done an especially good job

Sedana Medical publishes its Annual Report for 2019

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announce that its Annual Report for 2019 has been published and is available on www.sedanamedical.com under Investors.For additional information, please contact:Christer Ahlberg, vd, Sedana Medical ABMobil: +46 70 675 33 30E-post: christer.ahlberg@sedanamedical.comMaria Engström, CFOMobile: +46 70 674 33 30E-mail: maria.engstrom@sedanamedical.com Sedana Medical is listed on Nasdaq First North Growth Market in Stockholm.The company's Certified Adviser is Erik Penser Bank, +46 8 463 83 00, certifiedadviser@penser.se.

Revenio Group Corporation: Interim Report, January 1 - March 31, 2020

Revenio Group Corporation, Stock Exchange Release, April 22, 2020 at 9.00 amRevenio Group Corporation: Interim report January 1–March 31, 2020 Figures in brackets refer to the same period in the previous year, unless otherwise stated. Reasonable quarter; effects of the COVID-19 pandemic began to appear towards the end of the quarter January–March 2020 · Net sales totaled EUR 11.9 (8.4) million, up 41.5% · Operating profit was EUR 2.4 (2.6) million, down 5.8% · EBITDA was EUR 3.1 (2.9) million, up 7.4% · The currency-adjusted growth of net sales in January–March was 40.

Annual General Meeting in Oncopeptides AB (publ)

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, with registered office in the municipality of Stockholm, (“Oncopeptides” or the “Company”) are hereby given notice to attend the Annual General Meeting to be held at Tändstickspalatset, Västra Trädgårdsgatan 15, Stockholm, Sweden, Tuesday 26 May 2020 at 2.00 p.m. Registration for attendees will commence at 1.30 p.m. Due to the current pandemic (COVID-19), Oncopeptides has taken a number of precautionary measures ahead of the Annual General Meeting aimed at keeping the meeting short and efficient and reduce the risk of

Correction of reference in announced press release

Polygon AB (publ) has yesterday April 21, 2020 at 16:00 CEST issued a press release regarding the publication of its Annual Report for 2019.The press release incorrectly referred to the information being published pursuant to the EU Market Abuse Regulation, whereas the correct reference should have been that the information was published pursuant to the Swedish Securities Market Act. Accordingly, for the avoidance of doubt, the company did not consider any information in the Annual Report or the press release to constitute inside information under the EU Market Abuse Regulation.

Outokumpu – Publishing of the first-quarter 2020 results

Outokumpu OyjPress releaseApril 22, 2020 at 9.00 am EESTOutokumpu – Publishing of the first-quarter 2020 results Outokumpu will publish the first-quarter 2020 results on Wednesday, May 6, 2020 at approximately 9.00 am EEST. A conference call for investors and analysts will be held on Wednesday, May 6, 2020 at 3.00 pm EEST (8.00 am US EST, 1.00 pm UK, 2.00 pm CET). The results call will be hosted by Outokumpu’s CEO Roeland Baan and CFO Pia Aaltonen-Forsell. To participate in the conference call, please dial in 10−15 minutes before the beginning of the event: Finland: +358 9 4245

Getinge Interim Report for January-March 2020: Intense efforts to help hospitals in the COVID-19 pandemic

“The quarter was dominated by the COVID-19 pandemic and the huge need for advanced ventilators and ECMO therapy at intensive care units around the world. Our leading global positions in these fields contributed to a 47% organic order growth, says Mattias Perjos, President & CEO Getinge. “We expect to see continuing strong demand in both areas since demand is far outstripping supply”. Consequently, Getinge announced at the start of April an increased production capacity of ventilators by 160% compared with 2019. Getinge expects the high delivery rate to continue into 2021 and

Interim report January–March 2020

Quote from Therese Hillman, Group CEO “To further strengthen competitiveness and increase efficiency, we initiated a full integration with Red Tiger during the quarter. Red Tiger keeps performing above our expectations with its award-winning games and the expansion to new markets continues. Combined with a strong product pipeline, new regulated market entries and the Live Casino opportunity for NetEnt, this puts us in a good position to continue delivering profitable growth in 2020.” First quarter of 2020  · Revenues for the first quarter amounted to 518 (418) SEKm · EBITDA was

Edogawa Hospital first in Japan to order Elekta Unity MR-Linac

Cutting-edge technology to address need for treating cancer with greatest precisionTOKYO, April 22, 2020 – People living with cancer in Japan will have access to the most technically advanced radiotherapy treatment available as Edogawa Hospital acquires an Elekta Unity MR-Linac system. Elekta Unity gives doctors the “vision” to zero in on tumors and avoid healthy tissues and thereby addresses an unmet need in cancer therapy – it will enable Edogawa Hospital’s clinicians to confidently see and track the target during treatment and respond accordingly, and to adapt the treatment plan daily to

Invitation to SRV Group Plc’s January – March 2020 interim report audiocast and conference call

SRV GROUP PLC     INVESTOR NEWS     22 APRIL 2020      8.30 EET Invitation to SRV Group Plc’s January – March 2020 interim report audiocast and conference call SRV Group Plc will publish January – March 2020 interim report on Wednesday 29 April 2020 at 8.30 EET. The report can be found on the company's website www.srv.fi/en/investors. SRV will present the financial result to the analysts, fund managers, investors and representatives of the media at a combined audiocast and conference call on the same day starting at 12.00 EET. The event will be held in Finnish and hosted by CEO

SpareBank 1 SR-Bank ASA (SRBANK): Increased loan impairments and reduced financial income

In connection with the presentation of its results for the fourth quarter of 2019, SpareBank 1 SR-Bank ASA stated that its return on equity after tax target for the financial year 2020 was 12%. At the time, the Norwegian economy was virtually unaffected by the Covid-19 situation. As a result of the significant consequences in connection of the partial lockdown of society, combined with the substantial fall in oil prices, the marked downturn in activity has resulted in uncertainty and weaker profitability for many of our customers. SpareBank 1 SR-Bank ASA is a solid bank and at the end

Opus revises its financial targets 2020

Opus’ established financial targets from April 2019 have been revised by the Board.Following the acquisition of a majority stake of Opus by Ograi and the improved headroom with respect to the leverage covenant under the new financing from Ares, the Opus Board of Directors has decided to remove the leverage target as of 2020. The financial targets for revenue growth and EBITA margin, adopted by the Board in early 2019, remain unchanged. The 2020 targets are as follows: · 5-10% annual revenue growth (Organic and acquisitive growth based on 3-year CAGR) · 15% EBITA margin

Zengun Group AB 2019 Annual General Meeting

At the Zengun Group AB Annual General Meeting, held on 21 April 2020, it was resolved that the board should comprise five members, without deputies. Board members Jan Örnevik, Ulf Jonsson, Henrik Lif, Cecilia Safae and Tobias Örnevik were re-elected. Jan Örnevik was re-elected Chairman of the Board. The proposed appropriation of profits was approved and the meeting resolved that the profit for the year be carried forward. The meeting resolved that the remuneration to the Board of Directors should remain unchanged at SEK 160,000 per member, including the Chairman of the Board.

The Zengun Group Annual Report for 2019 is now published

The Annual Report 2019 for Zengun Group AB is now available in Swedish and English language versions at the company website as a pdf-document. Please visit www.zengun.se.  For more information, please contact: Sture Nilsson, VD och koncernchef +46 (0)70 580 04 15Anna-Carin Bjelkeby, Ekonomi- och finansdirektör +46 (0) 70 580 62 25 Prior to publication, this information constituted insider information. This information is of such a kind that Zengun Group AB (publ) is legally required to disclose pursuant to the EU’s Market Abuse Regulation. This information was submitted through

There are no items matching the current filter
There are no more items matching the current filter
Back to top